10 Undervalued Counter Cyclical Stocks to Buy Now
Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.
Tenet Healthcare Corp (THC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lone Pine Capital Stephen Mandel | 2,258,717 | $426,242,485 | +27% | 3.4% |
| 2. | Glenview Capital Larry Robbins | 1,524,854 | $287,755,198 | -24% | 7.22% |
| 3. | AQR Capital Management Cliff Asness | 1,442,588 | $272,230,699 | -37% | 0.12% |
| 4. | Eminence Capital Ricky Sandler | 790,302 | $149,137,890 | +29% | 3.42% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 671,700 | $126,756,507 | +58% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.07 | 11,000 | $473,770.00 | 392,815 | 2022-10-26 | Filing | |
| $13.02 | 6,153 | $80,112.06 | 24,882 | 2020-03-17 | Filing | |
| $17.28 | 20,000 | $345,600.00 | 49,413 | 2020-03-16 | Filing | |
| $14.79 | 2,560 | $37,862.40 | 6,726 | 2020-03-16 | Filing | |
| $15.42 | 1,000 | $15,420.00 | 8,845 | 2020-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $177.52 | 361 | $64,084.72 | 16,804 | 2026-05-28 | Filing | |
| $176.89 | 905 | $160,085.45 | 17,165 | 2026-05-28 | Filing | |
| $175.13 | 713 | $124,867.69 | 18,070 | 2026-05-28 | Filing | |
| $173.97 | 1,690 | $294,009.30 | 18,783 | 2026-05-28 | Filing | |
| $173.12 | 1,969 | $340,873.28 | 20,473 | 2026-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,704,644 | $1,642,653,293 | 0.03% | |
| 2. | 7,776,579 | $1,467,518,141 | 0.08% | |
| 3. | 4,316,887 | $814,639,746 | 0.04% | |
| 4. | 3,911,408 | $738,121,804 | 0.01% | |
| 5. | 3,834,961 | $723,650,402 | 0.76% |
News See All
10 Cheap NYSE Stocks to Buy According to Analysts
On May 13, Sarat Sethi, DCLA managing partner, appeared on CNBC's 'The Exchange' to discuss the current investment strategies.
Tenet Healthcare Corporation (NYSE:THC) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to Tenet Healthcare's First Quarter 2026 Earnings Conference Call. [Operator Instructions] I'll now turn the call over to your host, Mr.
11 Best Stocks You'll Wish You Bought Sooner
Discussions on best investment opportunities remain in the spotlight even as the macroeconomic signals point to looming uncertainty and shifts in the capital allocation strategies.
Here's What Analysts Are Saying About Tenet Healthcare Corporation (THC) Post Earnings
Tenet Healthcare Corporation (NYSE:THC) is one of the best strong buy healthcare stocks to invest in.
11 Best Strong Buy Healthcare Stocks to Invest In
On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the stock market and the recent price action in stocks.
Tenet Healthcare (THC) Benefiting from Capital Return Potential, Says Wells Fargo
Following Tenet Healthcare Corporation’s (NYSE:THC) Q4 update, Wells Fargo lifted its target from $229 to $265 and maintained its Overweight rating on February 16.
15 Undervalued Momentum Stocks That Are Taking Off
“It seems like the momentum stocks that have got us here still remain in favor with our customers.” This was highlighted by Steve Sosnick, Chief Strategist at Interactive Brokers, in a late December...
Tenet Healthcare Corporation (NYSE:THC) Q4 2025 Earnings Call Transcript
Will McDowell: Good morning, and welcome to Tenet Healthcare Corporation's Fourth Quarter 2025 Earnings Conference Call.
Ambulatory Care Drives Tenet Healthcare Corporation (THC)’s Strong Earnings Momentum
On December 18, TheFly reported that Morgan Stanley reiterated its Overweight rating on THC and maintained a $247 price target, citing confidence in the company’s operational execution and strong ...